These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 23213180)
1. Cancer and natural selection. Fillon M J Natl Cancer Inst; 2012 Dec; 104(23):1773-4. PubMed ID: 23213180 [No Abstract] [Full Text] [Related]
2. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance. Shapira A; Livney YD; Broxterman HJ; Assaraf YG Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184 [TBL] [Abstract][Full Text] [Related]
3. Cancer therapy: an evolved approach. Willyard C Nature; 2016 Apr; 532(7598):166-8. PubMed ID: 27075079 [No Abstract] [Full Text] [Related]
4. Preface: National Cancer Act. Smalley KS Adv Pharmacol; 2012; 65():xi-xiii. PubMed ID: 22959037 [No Abstract] [Full Text] [Related]
5. Targeted therapy: overcoming drug resistance with clinical cancer genome. Ziogas DE; Katsios CS; Tzaphlidou M; Roukos DH Expert Rev Anticancer Ther; 2012 Jul; 12(7):861-4. PubMed ID: 22845399 [No Abstract] [Full Text] [Related]
6. Overcoming multidrug resistance in cancer: 35 years after the discovery of ABCB1. Gillet JP; Gottesman MM Drug Resist Updat; 2012; 15(1-2):2-4. PubMed ID: 22465109 [No Abstract] [Full Text] [Related]
12. Assessing cancer with a blood draw. Azvolinsky A J Natl Cancer Inst; 2012 Dec; 104(23):1774-5. PubMed ID: 23213181 [No Abstract] [Full Text] [Related]
13. Functional drug-gene interactions in lung cancer. Smida M; Nijman SM Expert Rev Mol Diagn; 2012 Apr; 12(3):291-302. PubMed ID: 22468819 [TBL] [Abstract][Full Text] [Related]
14. [Signal transduction and its targeting from the cancer molecular genetic platform: applications and perspectives in pulmonary pathology]. Merlio JP Ann Pathol; 2011 Nov; 31(5 Suppl):S40-2. PubMed ID: 22054456 [No Abstract] [Full Text] [Related]
15. Biology-driven phase II trials: what is the optimal model for molecular selection? Andre F; Delaloge S; Soria JC J Clin Oncol; 2011 Apr; 29(10):1236-8. PubMed ID: 21343554 [No Abstract] [Full Text] [Related]
16. Array-based pharmacogenomics of molecular-targeted therapies in oncology. Sanoudou D; Mountzios G; Arvanitis DA; Pectasides D Pharmacogenomics J; 2012 Jun; 12(3):185-96. PubMed ID: 22249357 [TBL] [Abstract][Full Text] [Related]
17. Evolution of targeted therapies in cancer: opportunities and challenges in the clinic. Santhosh S; Kumar P; Ramprasad V; Chaudhuri A Future Oncol; 2015; 11(2):279-93. PubMed ID: 25591839 [TBL] [Abstract][Full Text] [Related]
18. From traditional molecular biology to network oncology. Ziogas DE; Katsios C; Roukos DH Future Oncol; 2011 Feb; 7(2):155-9. PubMed ID: 21345133 [No Abstract] [Full Text] [Related]
19. New skin cancer target could delay drug resistance. Oncology (Williston Park); 2013 Mar; 27(3):164. PubMed ID: 23687783 [No Abstract] [Full Text] [Related]